IOL Chemicals And Pharmaceuticals Ltd.

IOLCP

₹94.2

2.22% (2.05)

Market Cap

₹2,705 Cr.

P/E

25.75

Key Ratios

Edit Ratio's

Market cap

2,705 Cr

25.75

Prom Holding

52.62 %

ROE (%)

5.99

ROCE (%)

8.62

Div Yield (%)

4.25

Sales

2,128 Cr

OPM (%)

10.02 %

Debt to Equity

0.07

Edit Ratio's

About

Established in 1986, IOL Chemicals & Pharmaceuticals Ltd. is a leading generic pharmaceutical … Read more

Low

52W Range

High

107

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

3 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
ROE

Roe has decreased vs 10 year trend
Share price

Share price has increased over last 10 years but more due to rerating
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

30 %

(as of Mar 25)

Source/Historic

Ibuprofen - Global Market Share

30 %

(as of Mar 25)

Source/Historic

Isobutyl Benzene (IBB) Global Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Capex

Raw Material Break-Up

Asset Break-Up

Operational Metrics

Manufacturing Capacity - Ethyl Acetate (MTPA)
Source
Manufacturing Capacity - Isobutyl Benzene (IBB) (MTPA)
Source
Manufacturing Capacity - Acetyl Chloride (MTPA)
Source
Manufacturing Capacity - Ibuprofen (MTPA)
Source
Manufacturing Capacity - Paracetamol (MTPA)
Source
Manufacturing Capacity - Metformin (MTPA)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

HLE Glascoat Ltd.
BCL Industries Ltd.

Customers

Abbott India Ltd.
Akzo Nobel India Ltd.
BASF India Ltd.
Zydus Lifesciences Ltd.
Cipla Ltd.
DIC India Ltd.
Granules India Ltd.
Indoco Remedies Ltd.
ITC Ltd.
Nectar Lifesciences Ltd.
Sanofi India Ltd.
Strides Pharma Science Ltd.
Sun Pharmaceutical Industries Ltd.
Uflex Ltd.
UPL Ltd.
Alkem Laboratories Ltd.
Aristo Pharmaceuticals Limited
Kern Pharma
SinoChem Limited
Tabuk Pharmaceuticals

Showing 5 of 20

FAQs on IOL Chemicals And Pharmaceuticals Ltd. Business

What does IOL Chem & Pharma do?

Established in 1986, IOL Chemicals & Pharmaceuticals is a leading generic pharmaceutical company in India, specializing in API's, bulk drugs, and specialty chemicals across various therapeutic categories for both domestic and international markets.

Who are the competitors of IOL Chem & Pharma?

IOL Chem & Pharma major competitors are Granules India, Laxmi Organic Inds., Morepen Laboratories, Solara Active Pharma, SMS Pharmaceuticals, Hester Biosciences, Bajaj Healthcare.
Market Cap of IOL Chem & Pharma is ₹2,705 Crs.
While the median market cap of its peers are ₹2,543 Crs.

Is IOL Chem & Pharma financially stable compared to its competitors?

IOL Chem & Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	May Aug	Mar Jun Sep Dec	Mar Jun Sep Dec	Feb Mar May Jun Aug Sep Dec	Mar Jun Sep Dec	Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

IOL Chemicals And Pharmaceuticals Ltd.

Why IOLCP has a low PE? - Candor Investing

Analysis: IOL Chemicals and Pharmaceuticals - Dr Vijay Malik

View the discussion on ValuePickr

IOLCP vs Solara - Ibuprofen Competition - Value Educator

Analysis Of IOLCP - Sadhan

Chemical Sector

Chemicals Sector - Breakdown and Value Chain - PPFAS

Chemical Industry - Top Down - Capital Mind

Battery Chemistry Of EV's - Value Educator

Indian agrichemical overview - a sectoral perspective - ValuePickr

Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan

Understanding the Agri-Inputs Industry - PPFAS

Pesticides Industry Primer - ValuePickr

Flavours & Fragrances: Everything you need to know about this sector! - Anish Moonka

Overview of Shelf-Life Extension and Aroma Chemicals - Camlin Fine Sciences

Understanding The Dyes & Pigments Industry - Tycoon Mindset

A Primer On Speciality Chemicals - The Investing Hub

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

IOL Chemicals And Pharmaceuticals Ltd.

IOL Chemicals And Pharmaceuticals Ltd.

Key Ratios

About

Timeline

Company Timeline

6 Yes

3 Neutral

8 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Promoter Holding

Retail Holding

Revenue Recognition

Price & Performance

Working Capital

Debt

Capex vs ROCE

Balance Sheet Strength

Current vs Historic Valuation

ROE

Share price

Sales Growth

Margin Stability

ROCE Strength

Product Wise Break-Up

UNLOCK PREMIUM

Segment Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Operating Profit Break-Up

UNLOCK PREMIUM

Capex

UNLOCK PREMIUM

Raw Material Break-Up

UNLOCK PREMIUM

Asset Break-Up

UNLOCK PREMIUM

What does IOL Chem & Pharma do?

Who are the competitors of IOL Chem & Pharma?

Is IOL Chem & Pharma financially stable compared to its competitors?

SIGN UP FOR FREE